thalidomide has been researched along with gdc-0973 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balabanov, S; Cozzio, A; Dummer, R; Fehrenbacher, B; French, LE; Guenova, E; Hoetzenecker, W; Jochum, W; Kamarachev, J; Kerl, K; Metzler, G; Roider, E; Schaller, M; Signer, C | 1 |
1 other study(ies) available for thalidomide and gdc-0973
| Article | Year |
|---|---|
Individualized treatment approaches for Langerhans cell histiocytosis.
Topics: Adrenal Cortex Hormones; Adult; Aged, 80 and over; Azetidines; Bone Diseases; Dermatologic Agents; Female; Histiocytosis, Langerhans-Cell; Humans; Male; Middle Aged; Off-Label Use; Piperidines; Skin Diseases; Thalidomide | 2018 |